Skip to main content

Rochelle Nataloni, Contributing Editor

Rochelle Nataloni, Contributing Editor
These programs combine individual patient visits with a group hands-on experience, education, and peer support. 
Rochelle Nataloni, Contributing Editor
Dr Beck discusses her research characterizing the epithelial tight junction defects at the molecular level in atopic dermatitis and the future of eczema treatment.
Rochelle Nataloni, Contributing Editor
Yolanda R. Helfrich, MD, discusses exciting developments in rosacea research, as well as what inspired her to specialize in the field.
Rochelle Nataloni, Contributing Editor
Kaiser Permanente researcher and clinician has studied how inflammatory effects of psoriasis can impact the entire body.
Rochelle Nataloni, Contributing Editor
Eric Simpson, MD, discusses the burden of disease, disease prevention, and novel therapies.
Rochelle Nataloni, Contributing Editor
Robert Sidbury, MD, MPH, talks about new eczema medications, his research, and the importance of primary care providers understanding how impactful AD can be.  
Rochelle Nataloni, Contributing Editor
Gil Yosipovitch, MD, reflects on the strides being made in the world of eczema and atopic dermatitis, his work on itch as a complex disease, and future plans that look at the effect of itch by targeting pathways in the brain.
Rochelle Nataloni, Contributing Editor
Dr Gelfand discusses the evolving landscape of psoriasis research and a multidisciplinary perspective to treating patients who present with inflammatory conditions in multiple organ systems.
Rochelle Nataloni, Contributing Editor
Alice Gottlieb, MD, PhD, discusses a range of topics on psoriasis including her past and current research and future outlook of the disease state.  
Rochelle Nataloni, Contributing Editor
Large dermatology practices and private equity firms are acquiring practices with increasing regularity. The impact of what it will mean for the specialty in the long run is not yet known.
Back to Top